In 2 clinical trials, DUPIXENT was proven to provide better breathing that lasts through 52 weeks.
WHEN USED WITH COPD INHALERS,* DUPIXENT CAN:
The most common side effects in COPD patients were injection site reactions, common cold symptoms (nasopharyngitis), high count of a certain white blood cell (eosinophilia), viral infection, back pain, inflammation inside the nose (rhinitis), diarrhea, stomach problems (gastritis), joint pain (arthralgia), toothache, headache, and urinary tract infection.
View all the possible side effects of DUPIXENT in patients with inadequately controlled chronic obstructive pulmonary disease.
*COPD inhalers are considered standard of care (SOC), which refers to a typical treatment approach prescribed by a healthcare professional for COPD.
†Assessed by SGRQ, a quality of life tool which measures COPD symptoms, physical activity, emotional well-being, and social functioning. In 2 trials, 51% of patients who received DUPIXENT + SOC experienced a quality of life improvement vs 43% and 47% with placebo + SOC. In one trial, results are descriptive, no definitive conclusions can be made.
If I were to offer myself a bit of advice, I'd say even if you're experiencing mild worsening symptoms, talk to your pulmonologist right away. Sometimes better breathing is just a short conversation away.
Want to try DUPIXENT for yourself? Set up an appointment
with your pulmonologist to talk about DUPIXENT as an add-on
treatment option for your COPD. Get ready for your visit by
creating a checklist to help guide the conversation.
Do not stop taking your corticosteroid medicines unless instructed by your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine to come back.
The average age of patients in these studies was 65. Patients had an average of 2.2 moderate-to-severe flare-ups in the past year, and an average time of 9 years since their initial COPD diagnosis.
DUPIXENT can cause serious side effects, including:
The most common side effects of DUPIXENT include: